MRNA shot into tumors aims to rally immune system against cancer
Disease control
Not yet recruiting
This early-stage study tests a new mRNA-based immunotherapy called PMC2129G12 for people with advanced solid tumors that have not responded to standard treatments. The treatment is injected directly into the tumor and is designed to help the body's immune cells attack the cancer.…
Phase: PHASE1, PHASE2 • Sponsor: IntraAb, Inc. • Aim: Disease control
Last updated May 17, 2026 04:13 UTC